Superior consistency of ambulatory blood pressure monitoring in children: Implications for clinical trials

Journal of Hypertension

Volumn 27, Issue 8, 2009, Pages 1568-1574

  Gimpel, Charlotte ^a   Wühl, Elke ^a   Arbeiter, Klaus ^b   Drozdz, Dorota ^c   Trivelli, Antonella ^d   Charbit, Marina ^e   Gellermann, Jutta ^f   Dusek, Jiri ^g   Jankauskiene, Augustina ^h   Emre, Sevinc ⁱ   Schaefer, Franz ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d G GASLINI INSTITUTE   (Italy)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^h VILNIUS UNIVERSITY   (Lithuania)

ⁱ ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Adolescents; Ambulatory blood pressure measurement; Antihypertensive drugs; Children; Clinical trial; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; RAMIPRIL;

ADOLESCENT; ADULT; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CHILD; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 68449100597     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32832cb2a8     Document Type: Article

References (33)

1. Wühl E, Witte K, Soergel M, Mehls O, Schaefer F, for the German Working Group on Pediatric Hypertension. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 2002; 20:1995-2007.
2. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114:555-576.
3. Lurbe E, Torro I, Alvarez V, Nawrot T, Paya R, Redon J, Staessen J. Prevalence, persistence and clinical significance of masked hypertension in youth. Hypertension 2005; 45:493-498.
4. Wühl E, Hadtstein C, Mehls O, Schaefer F, ESCAPE trial group. Home, clinic, and ambulatory blood pressure monitoring in children with chronic renal failure. Pediatr Res 2004; 55:492-497.
5. Wühl E, Mehls O, Schaefer F, ESCAPE trial group. Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 2004; 66:768-776.
6. Prader A, Largo RH, Molinari L, Issler C. Physical growth in Swiss children from birth to 20 years of age. Helv Paediatr Acta 1989; 52:S1-S125.
7. Schaefer F, Georgi M, Wühl E, Schärer K. Body mass index and percentage fat mass in healthy German schoolchildren and adolescents. Int J Obes Relat Metab Disord 1998; 22:461-469.
8. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerularfiltration rate in infants, children and adolescents. Pediatr Clin North Am 1987; 34:571-590.
9. Sorof J, Daniels S. Obesity hypertension in children. A problem of epidemic proportions. Hypertension 2002; 40:441-447.
10. Flynn JT, Newburger JW, Daniels SR, Sanders SP, Portman RJ, Hogg RJ, et al. A randomized, placebo-controlled trail of amlodipine in children with hypertension. J Pediatr 2004; 145:353-359.
11. Hansen TW, Kikuya M, Thijs L, Björklund-Bodegard K, Kuznetsova T, Ohkubo T, et al. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7030 individuals. J Hypertens 2007; 25:1554-1564.
12. Eguchi K, Pickering TG, Hoshide S, Ishikawa J, Ishikawa S, Schwartz JE, et al. Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am J Hypertens 2008; 21:443-450.
13. Gueyffier F, Cornu C, Bossard N, Mercier C, Poncelet P, Sebaoun A, et al. Prognostic importance of ambulatory arterial pressure monitoring in France. Initial results of the OCTAVE II study. Arch Mal Coeur Vaiss 1999; 92:1151-1157.
14. Portman RJ, Yetman RJ, West MS. Efficacy of 24-h ambulatory blood pressure monitoring in children. J Pediatr 1991; 118:842-849.
15. Gellermann J, Kraft S, Ehrich JH. Twenty-four-hour ambulatory blood pressure monitoring in young children. Pediatr Nephrol 1997; 11:707-710.
16. Varda NM, Gregoric A. Twenty-four-hour ambulatory blood pressure monitoring in infants and toddlers. Pediatr Nephrol 2005; 20:798-802.
17. Koch VH, Colli A, Saito Ml, Furusawa EA, Ignes E, Okay Y, Mion Junior D. Comparison between casual blood pressure and ambulatory blood pressure monitoring parameters in healthy and hypertensive adolescents. Blood Press Monit 2000; 5:281-289.
18. Ferraris J, Ghezzi L, Waismann G, Krmar RT. ABPM vs office blood pressure to define blood pressure control in treated hypertensive paediatric renal transplant recipients. Pediatr Transplant 2007; 11:24-30.
19. Lopes CA, Leráio AC, Mion D, Koch V, Wajchenberg BL, Rosenbloom AL. Ambulatory blood pressure monitoring (ABPM) in normotensive adolescents with type 1diabetes. Pediatr Diabetes 2002; 3:31-36.
20. Stergiou GS, Alamara CV, Salgami EV, Vaindirlis IN, Dacou-Voutetakis C, Mountokalakis TD. Reproducibility of home and ambulatory blood pressure in children and adolescents. Blood Press Monit 2005; 10:143-147.
21. Sorof JM, Cardwell G, Franco K, Portman RJ. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension 2002; 39:903-908.
22. Matsuoka S, Awazu M. Masked hypertension in children and young adults. Pediatr Nephrol 2004; 19:651-654.
23. Kavey RE, Kveselis DA, Atallah N, Smith FC. White coat hypertension in childhood: evidence for end-organ effect. J Pediatr 2007; 150:491-497.
24. Stergiou GS, Alamara CV, Kalkana CB, Vaindirlis IN, Stefanidis CJ, Dacou-Voutetakis C, Mountokalakis TD. Out-of-office blood pressure in children and adolescents: disparate findings by using home or ambulatory monitoring. Am J Hypertens 2004; 17:869-875.
25. Mitsnefes MM, Kimball TR, Daniels SR. Office and ambulatory blood pressure elevation in children with chronic renal failure. Pediatr Nephrol 2003; 18:145-149.
26. Stergiou GS, Baibas NM, Gantzarou AP, Skeva II, Kalkana CB, Roussias LG, Mountokalakis TD. Reproducibility of home, ambulatory, and clinic blood pressure: implications for the design of trials for the assessment of antihypertensive drug efficacy. Am J Hypertens 2002; 15:101-104.
27. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 2008; 300:924-932.
28. Samuels JA, Franco K, Sorof JM. Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomised, cross over trial. Pediatr Nephrol 2006; 21:92-95.
29. Skov K, Eiskjaer H, Hansen HE, Madsen JK, Kvist S, Mulvany MJ. Treatment of young subjects at high familial risk of future hypertension with an angiotensin-receptor blocker. Hypertension 2007; 50:89-95.
30. Proesmans W, Van Wambeke I, Van Dyck M. Long term therapy with enalapril in patients with nephrotic-range proteinuria. Pediatr Nephrol 1996; 10:587-589.
31. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegard K, et al. International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO) investigators. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007; 370:1219-1229.
32. Wühl E, Hadtstein C, Mehls O, Schaefer F, ESCAPE trial group. Ultradian but not circadian blood pressure rhythms correlate with renal dysfunction in children with chronic renal failure. J Am Soc Nephrol 2005; 16:746-754.
33. Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M, et al. Prognostic significance of blood pressure and heart rate variabilities. The Ohasama Study. Hypertension 2000; 36:901-906.